RAVDEEP KHANUJA: Open Payments
NPI 1750433256 · POPLAR BLUFF, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$122,396 in 174 payments from 10 companies in 2025. Trend: 2023 $26,259 · 2024 $22,779 · 2025 $122,396
Speaker / faculty: $95,295Consulting: $14,350Travel & lodging: $8,980Food & beverage: $3,764Education: $8
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 67 | $69,396 |
| E.R. Squibb & Sons, L.L.C. | 36 | $30,966 |
| Alkermes, Inc. | 45 | $21,368 |
| Janssen Pharmaceuticals, Inc | 8 | $213 |
| Neurocrine BioSciences, Inc. | 8 | $177 |
| Otsuka America Pharmaceutical, Inc. | 4 | $161 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Lundbeck LLC | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: UZEDY, LYBALVI, COBENFY, ARISTADA, INGREZZA, ABILIFY MAINTENA, SPRAVATO, INVEGA SUSTENNA.
Industry payments across MO — which companies pay providers there.
